MedTrace Logo

REassessement After Hospitalization for Sars-COV-2 disordER

NCT04443257 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2023-02-21

No results posted yet for this study

Summary

Currently, the sequelae and short-term medical and psychological impact of the sars-cov-2 infection ("CoVID-19") remain poorly described. The clinical and functional sequelae that may persist after acute sars-cov-2 ("CoVID-19") infection are essential to explore, in order to ensure the best possible follow-up of patients after discharge from hospital.

Conditions

  • Sars-CoV2

Interventions

OTHER

assessment of the sequelae after hospitalization for Sars-COV-2

the incidence of chronic respiratory failure and fibrosis, as well as of comorbidities including cardiovascular, metabolic, renal, hepatic, neurological, and psychological diseases

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-08
Primary Completion
2022-02-18
Completion
2022-02-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04443257 on ClinicalTrials.gov